Neurol. pro Praxi, 2002; 4: 209-213

Epilepsia a porfýria

MUDr. Darina Buranová Ph.D1, prof. MUDr. Pavel Varsik DrSc1, MUDr. Marek Baláž2, MUDr. Branislav Kollár1
1 I. neurologická klinika FNsP, Bratislava
2 Centrum pro abnormální pohyby a parkinsonismus, I. neurologická klinika LF MU, FN u sv. Anny, Brno

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Buranová D, Varsik P, Baláž M, Kollár B. Epilepsia a porfýria. Neurol. praxi. 2002;3(4):209-213.

Podľa literárnych údajov patrí výskyt epileptických záchvatov medzi významné prejavy funkčnej poruchy a poškodenia centrálného nervového systému (CNS) u akútnej intermitentnej porfýrie (AIP). Podarilo sa nám zozbierať literárne údaje o tridsiatich prípadoch výskytu epileptických záchvatov u pacientov s akútnou intermitentnou porfýriou. Súbor sme rozdelili do troch skupín, podľa možnej kauzálnej súvislosti epilepsie s AIP: skupina s nepravdepodobnou, možnou a istou súvislosťou medzi oboma skupinami ochorení.

Klúčové slová: epilepsia, akutná intermitentná porfýria, antiepileptika.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aggarval A, Quint DJ, Lynch JP. MR imaging of porphyric encephalopathy, AJR 1994; 162: 1218-1220. Go to original source... Go to PubMed...
    2. Biagini R, Tigniani R, Fifi AR, Nappini L. Acute inermittent porphyria and epilepsy.Arch Dis Child 1979; 54: 644-645. Go to original source... Go to PubMed...
    3. Birchfield RI, Cowger Ml. Acute intermittent porphyria with seizures. Am J Dis Child 1966; 112, 561-565. Go to original source... Go to PubMed...
    4. Bonkowsky HL, Sinclair PR, Emery S, Sinclair JF. Seizure management in acute hepatic porphyria: risk of valproate and clonazepam, Neurology 1980; 30: 558-592. Go to original source... Go to PubMed...
    5. Buranová D, Varsik P, Baláž M, Božek P. Akútna intermitentná porfýria a prejavy poškodenia nervového systému. Neurologie pro praxi 2001; 3 (2): 147-152.
    6. Bylesjö I, Forsgren L, Lithner F, Boman K. Epidemiology and Clinical Characteristics of Seizures in Patients with Acute Intermitent Porphyria, Epilepsia, 1996, 37 (3): 230-235. Go to original source... Go to PubMed...
    7. Davidson R. Acute porphyria and epilepsy: safety of clonazepam. Epilepsia 1991; 33: 108-111. Go to original source...
    8. Gaida-Hommernick B, Rieck K, Runge U. Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report. Epilepsia 2001; 42 (6), 793-795. Go to original source... Go to PubMed...
    9. Gretter T, Danner P, Nibbelink D, Green D, Sahs AL. The effect of diphenylhydantoin (Dilantin) on acute intermitent porphyria. Trans Am Neurol Assoc 1963; 88: 176-178. Go to PubMed...
    10. Goldberg A. Acute intermittent porphyria. Quart J Med 1959; 28: 183-189.
    11. Hahn M, Gildemeister OS, Krauss GL, Pepe JA, Lambrecht RW, Donohne S, Bonkowky HL. Effects of new anticonvulsant medication on porphyrin synthesis in cultured liver cells: Potential implications for patients with acute porphyria. Neurology 1997; 49: 97-105. Go to original source... Go to PubMed...
    12. Herrick AL, McColl KEL, Moore MR, Brodie MJ, Adamson AR, Goldberg A. Acute intermitent porphyria in two patients with anticolvusant therapy and with normal erythrocyte porfobilinogen deaminase activity. Br J Clin Pharmacol 1989; 27: 491-497. Go to original source... Go to PubMed...
    13. Kaplan PW, Lewis DV. Juvenile acute intermitent porphyria with hypercholesterolemia and epilepsy: a case report and review of the literature. J Child Neurol 1986; 1: 38-45. Go to original source... Go to PubMed...
    14. Kaupinnen R, Mustajoki P. Prognosis of acute intermitent porphyria: occurence of acute attacks, precipitating factors and associated diseases. Medicine 1992; 71: 1-13. Go to original source... Go to PubMed...
    15. Kučera P. Elektrodiagnostické sledovania nervu a svalu. In: Varsik P, Černáček J (Eds.). Neurologia I, Lufema, Bratislava 1997: 341-365.
    16. Kučera P, Krahulec B, Štrbová L. Skin sympathetic response in subclinical diabetic neuropathy diagnosis. In: Program and abstracts, Fifth Diabetic Neuropathy Sattelite San Jose (s.n.), 2000; 64 s. Go to original source...
    17. Kurča E, Kučera P, Štolc S, Štefek M, Solníková R, Gajdošík A. Medial plantar nerve conduction study in diabetic neuropathy diagnosis. Book of abstracts of Neurodiab XI, Aberdeen, Sept 7-9, 2001.
    18. Lai C-W. Carbamazepine in seizure management in acute intermitent porphyria. Neurology 1981; 31: 232. Go to original source... Go to PubMed...
    19. Larson AW, Wasserstrom WR, Felsher BF, Shih JC. Posttraumatic epilepsy and acute intermittent porphyria: effects of phenytoin, carbamazepine and clonazepam. Neurology, 1978; 28: 824-828. Go to original source... Go to PubMed...
    20. Magnussen CR, Doherty JM, Hess RA, Tschudy DP. Grand mal seizures and acute intermitent porphyria. Neurology 1975; 25: 1121-1125. Go to original source... Go to PubMed...
    21. Mustajoki P, Nordman Y. Early administration of heme arginaate for acute intermitent porphyria attacks. Arch Int Med 1993; 153: 2004-2008. Go to original source... Go to PubMed...
    22. Nielsen B, Thorn NA. Transient excess urinary excretion of antidiuretic material in acute intermitent porphyria. With hyponatremia and hypomagnesemia. Am J Med 1965; 38: 345-358. Go to original source... Go to PubMed...
    23. Pulman R. Porfýrie, In: Ďuriš I, Hulín I, Bernadič M (Eds.). Princípy internej medicíny, Bratislava, SAP 2001; 2951 s.
    24. Rowland LP (Edit.). Meritt´s neurology. 10th Ed. Lippincott Williams and Wilkins,Philadelphia USA, 2001, 1002.
    25. Sadeh M, Blatt I, Martonovits I, Karmi A, Goldhammer V. Treatment of porphyric convulsions with magnesium sulfate. Epilepsia, 1991, 32: 712-715. Go to original source... Go to PubMed...
    26. Suzuki A, Aso K, Ariyoshi C, Ishimarn M. Acute intermittent porphyria and epilepsy: safety of klonazepam. Epilepsia 1991; 33: 108-111. Go to original source... Go to PubMed...
    27. Stein JA, Tschudy DP. Acute intermitent porphyria. A clinical and biochemical study of 46 patients. Medicine 1970; 49:1-16. Go to original source... Go to PubMed...
    28. Suarez JI, Cohen ML, Larkin J, Kernich CA, Hricik DE, Daroff RB: Acute intermitent porphyria: clinicopathologic correlation. Report of case and review of the literature. Neurology 1997; 48: 1678-1683. Go to original source... Go to PubMed...
    29. Sykes RM. Acute intermitent porphyria, seizures and antiepileptic drugs: a report on 3-years old Nigerian boy. Seizure, 2001; 10 (1): 64-66. Go to original source... Go to PubMed...
    30. Wirtschafter JD, Turner FW, Dow RS. Convulsive seizures as the presenting manifestaation of intermitent porphyria. Neurology, 1960, 10: 787-792. Go to original source... Go to PubMed...
    31. Wyllie E (Ed.) The treatment of Epilepsy. Principle and practice. Lea & Febiger, Philadelphia, London, 1996; 1238.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.